Forced selling and lack of buyers is what crashed the entire market into the entry of a lifetime. Looks like AUY is heading there. A few months of below $900 gold will BK a lot of marginal players unable to handle debt loads.
How long will it take for buyers to creep back into oil? First "real" sign of inflation which may be a couple years off.
Digesting over weekend that storage is up and rig counts actually went up as the shell boys spend dumb money flowing into their coffers thinking their investing into a dip. ME actually increased production and Iran likely will be unloading the ready to flow cheap production being held back by embargo.
What is XOM worth with oil in 60's, after the coming shakeout in $30's? Looking for a buy in point if market rattles oil producers while oil stays in $30's while Saudies BK the shale, sand and deep producers. XOM could offer a huge short term discount for buyers, I hope.
I could see XOM being more sophisticated holders not selling and some smaller oil producers giving better discounts anyone here know some more high beta oil produers I should be watching?
Thanks ahead for anyone willing to share.
Capitualtion? Next week? Market is slowly digesting the Saudis see $60 oil as the future as the long term future as other power sources become more viable. Market share is more serious at $60 oil versus $100 oil and that is why the Saudis need to drive marginal oil into BK.
Saudis need to bankrupt the shale, sand and deep sea sources of oil. 30's should do that and the ME increasing production recently makes sense looking at it this way. Next year they gradually bring oil back up to 60's and will hold market share.
Who will want to invest in shale, sand and deep sea with this new world Saudi Arabia has defined for now.
On the good side consumers are not likely to see $100 oil for a long time. Saudis greed is what brought on the serious money being put into oil sands, shale and other expensive options.
Saudi's want to wreck the market and put fear into anyone wanting to invest in shale oil and deep sea drilling. If so they will need to keep the price in the $30 for a while to force the bankruptcy's.
Thought this ETF was designed to hold for 3-4 days. After the markets stew on oil and the Middle East actually ramping production into this market next week could see capitulation action. Just my guess.
The Supremes advised Parson's to use best expert opinion on this type of dispute to determine the award. That is where Parsons went way conservative and ended up with $130M that has nothing near the billions both parties thought -246 was worth in Sept '06. With interest adding $30,000 daily to the ill intent boyz liability we can all hope this comes to an end soon.
GLTA, but the boyz (they have already pocketed tens of millions in the money flow and cost of goods, more than they deserve)
Furthermore, this Court enjoys remedial flexibility to depart from strict application of the ordinary forms of relief where circumstances require.30 Nevertheless, courts of equity should attempt to balance that flexibility by a measure of concomitant restraint to
the Supreme Court held that “where the parties have a Type II preliminary agreement to negotiate in good faith, and the trial judge makes a factual finding, supported by the record, that the parties would have reached an agreement but for the defendant’s bad faith negotiations, the plaintiff is entitled to recover contract expectation damages.” Further, the court found that the factual conclusions made by the Court of Chancery support a finding that the LATS was a Type II preliminary agreement and that SIGA and Pharmathene could not, in good faith, propose terms of the definitive licensing agreement that were inconsistent with the LATS. Because this was the first time the Delaware Supreme Court addressed whether Delaware law recognizes Type II preliminary agreements or whether a plaintiff is entitled to recover expectation damages in connection with a breach of an obligation to negotiate a definitive agreement in good faith, the Supreme Court reversed the Court of Chancery’s damages award for reconsideration consistent with its ruling.
So much potential. Anyone know what is behind this recent price action?
"Cash Performance Bonuses" for what??? Inbred performance from top to top to top as they try to take care of each other. Did the law firm get a bonus as that has been the genius of everything Siga since Sept 06.
There are so many billion dollar valued companies pumped up by ETF's and short squeezing. As long as fresh money sees no other sector that can be hyped like Bio it's to the moon Alice.
Google the generics drugs that have gone up in price by 5-7 times their original price in the last couple of years. Buyouts and their games in the medical field.
K Street, The AMA , Biopharma are becoming known as the Medical Industrial Complex. Someone let me know when nosebleed is reached.
$30,000/day still going to Pharmathene. Siga management and it's cohorts are pocketing how much a day while this continues? Siga shareholders looking at their ROI flying out the window. Siga management doesn't seem to have any concern of ever actually returning anything to shareholders.
then the trial with Sparvax added to Depovax and the survival results:
Rabbits were exposed to a lethal dose of the anthrax causing bacterial spores (B. anthracis) 28 days following a single vaccination. The DepoVax/rPA vaccines provided good protection to animals against anthrax with a single dose, protecting a total of 15 of 24 animals across the three different rPA sources. As expected, control animals injected with a saline solution all succumbed to the anthrax challenge. Animals given a placebo DepoVax vaccine with no antigen also succumbed to anthrax, demonstrating that protection is mediated by the combination of DepoVax and rPA
Preliminary findings from the immunogenicity studies include:
• A single dose of DepoVaxTM-formulated anthrax vaccine produced sustained toxin-neutralizing antibody (“TNA”) titers detected in six of ten animals, starting between day 21 and 49. Animals receiving one dose of Biothrax had no detectable TNA titers.
• When a second dose of the DepoVaxTM-formulated vaccine was delivered, there was a significant increase in anthrax TNAs in all immunized animals within one week of the booster administration
Dec 20, 2006
VaxGen Inc. said late Tuesday that the Department of Health and Human Services (HHS) has terminated the company's $877.5 million contract to provide 75 million doses of a modern anthrax vaccine for civilian biodefense.
Brisbane-based VaxGen (Pink Sheets:VXGN) said HHS based the decision on its determination that VaxGen "failed to successfully cure the condition endangering performance" and failed to meet a milestone imposed by HHS that required VaxGen to initiate a clinical trial of the vaccine candidate by Dec. 18.
($877.5 million) - looking forward to the next quarterly conference call.
Despite the technical challenges, the production of anthrax spores in quantities great enough to cause a huge loss of life is not beyond the capability of a small group of equipped and funded terrorists. The small size and nondescript nature of a bioweapons facility could make detection of such a lab very difficult. Accordingly, the terrorist potential of anthrax will remain a threat for the foreseeable future
July 8, 2015
Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVaxTM